Archive for the ‘IMTECH’ Category
IMTECH celebrates CSIR’s foundation day
27 September 2015
CHANDIGARH: IMTECH, CSIR The Institute of Microbial Technology (IMTECH), Chandigarh, celebrated Council of Scientific and Industrial Research’s foundation day on Saturday by organizing several events including a lecture by Dr Rajesh S Gokhale, director of CSIR-Institute of Genomics and Integrative Biology, Delhi.
Speaking on “Science, Medicine and Respectful Insolence”, Gokhale said that the fruits of applying science to medicine, something that really didn’t happen in a big way until around 150 years ago, have markedly extended the life expectancy of humans…..
Novel Indian clotbuster
A new thrombolytic treatment discovered in India is poised to enter clinical trials following local authorities’ go-ahead on 17 August 2012. The home-grown clot-dissolving therapeutic could become the first innovative compound from an Indian public institute jointly developed with a US company. The drug, clot-specific streptokinase (CSSK), was developed by Girish…
Read more: http://www.nature.com/nbt/journal/v30/n10/full/nbt1012-903b.html
CSIR’s foundation day celebrated
26 September 2012
CHANDIGARH: The Institute of Microbial Technology (IMTECH) celebrated the foundation day of Central Scientific Institute of Research (CSIR), New Delhi, on Tuesday.
A lecture was delivered by prof Hans-Peter Klenk, head of department of microbiology, DSMZ-German Collection of Microorganisms & Cell Cultures, Germany. Prof Klenk spoke on “Classification of Bacteria and Archaea – from the beginning of microbiology to modern genome-based methods”……..
Tummy worms affect TB vaccine
11 September 2012
HYDERABAD: The age-old advice to regularly get children and adults dewormed has now got some solid scientific backing. An Indian research team have found that the presence of worms in the stomach makes tuberculosis vaccinations relatively ineffective.
……….Scientists from the Institute of Microbial Technology, Chandigarh, said infections with parasitic worms interfere with the BCG vaccine and render it less effective. The research report, highlighting reasons for the failure of the BCG vaccine was published in the latest issue of scientific journal Trends in Molecular Medicine…….
Read more: http://www.deccanchronicle.com/channels/cities/hyderabad/tummy-worms-affect-tb-vaccine-123
Scientists make case for new TB vaccines
29 August 2012
Researchers with the CSIR-Institute of Microbial Technology in Chandigarh, India, published a review on Tuesday of the ineffectiveness of the Bacillus Calmette-Guerin tuberculosis vaccine and the proposed use of lipidated-promiscuous-peptide vaccines….
Read more: http://vaccinenewsdaily.com/medical_countermeasures/319771-scientists-make-case-for-new-tb-vaccines/
Synthetic tuberculosis vaccines could save millions of lives
29 August 2012
WASHINGTON:
Cases of one of the world’s deadliest diseases-tuberculosis-are spiralling at an alarming rate, due to the ineffectiveness of the existing vaccines, a new study including an Indian-origin researcher has revealed.
“Tuberculosis is a global health threat, and it is a highly communicable disease that may influence practically anyone and everyone,” says senior author Javed Agrewala of the CSIR-Institute of Microbial Technology in Chandigarh, India……
Read more: http://truthdive.com/2012/08/29/Synthetic-tuberculosis-vaccines-could-save-millions-of-lives.html
Phase 1 trial of CSIR-IMTECH’s clot buster to start by end October
21 August 2012
The Institute of Microbial Technology (IMTECH), one of the national laboratories of the Council of Scientific & Industrial Research (CSIR) which recently received the Drugs Controller General of India (DCGI)’s nod for phase 1 trials for its clot buster drug is due to kick off the trial by end October at Veeda Clinical Research (Veeda CR), an Ahmedabad-headquartered CRO…..
Indigenous clot busting drug gets nod for clinical trials
17 August 2012
NEW DELHI: The first indigenous clot-busting drug to dissolve life-threatening blockages inside blood vessels of heart has now received official permission to start clinical trials within a couple of weeks.
…………..“This is a novel patented product with an additional benefit of reduced internal bleeding. It should not be equated with other commercial products. Barring a few vaccines, this is the first indigenous protein-based therapeutic, which can dissolve a clot within 30 minutes,” Girish Sahni, Director of Institute of Microbial Technology, Chandigarh, who led the research team told Deccan Herald……
Read more: http://www.deccanherald.com/content/272409/indigenous-clot-busting-drug-gets.html
Chandigarh scientist decodes fruit crop diseases
03 June 2012
CHANDIGARH: Overcoming a major roadblock in managing and controlling a devastating disease among pomegranate, mango and citrus, a Chandigarh-based scientist has cracked the gene-pattern of particular bacteria which causes this disease. India is the second largest exporter of pomegranate after Spain. The study has been published in the Nature.
A complete sequence of genes of the bacteria causing this disease which destroys pomegranate, mango and citrus crops has been decoded for the first time by an Institute of Microbial Technology (IMTECH) scientist Prabhu B Patil. The work has also been published in the recent issue of Journal of Bacteriology, an international journal…..
Read more: http://articles.timesofindia.indiatimes.com/2012-06-03/chandigarh/32005538_1_pomegranate-genes-mango
Genomes of mango, pomegranate pathogens decoded
In what they claim to be the first such reports on plant pathogens from India, scientists have decoded the complete genome sequence of bacteria affecting two important fruits of the country — mango and pomegranate.
The scientists from Chandigarh-based Institute of Microbial Technology (IMTECH), a laboratory of India’s Council of Scientific and Industrial Research (CSIR), have announced the fully annotated genome of the Xanthomonaspathogens that infect these fruits…
Read more: http://www.nature.com/nindia/2012/120511/full/nindia.2012.70.html
CSIR in the news.. 